Teva stock drops 4.5% in spite of Q2 profit beat, revenue match

Teva stock drops 4.5% in spite of Q2 profit beat, revenue match

Submitted by admin on August 2, 2018 - 11:10am
Source: 
Marketwatch
News Tags: 
Teva Pharmaceutical
earnings
Copaxone
Headline: 
Teva stock drops 4.5% in spite of Q2 profit beat, revenue match
snippet: 

Teva Pharmaceutical Industries Ltd. TEVA, -9.91% shares dropped nearly 5% in Thursday premarket trade in spite of the company reporting a second-quarter profit beat and revenue match.

Do Not Allow Advertisers to Use My Personal information